Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled glycopyrronium dose-finding study for drooling in Parkinson's disease
NL-OMON27582Not yet recruiting
- Sponsor
- Medisch Spectrum Twente
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of glycopyrronium in hypersalivation, sponsored by Medisch Spectrum Twente. Primary endpoint: Safety and tolerability of glycopyrronium inhalation powder. Planned start Jan 2017; status: not yet recruiting.
02
Drugs
glycopyrronium
03
Conditions
hypersalivation
Beyond the preview
Go deeper on NL-OMON27582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27582.